Pharmacology Tutoring – Factors Affecting Drug Action

Slides:



Advertisements
Similar presentations
Connecting Pharmacology with Therapeutics Clive Roberts.
Advertisements

Pharmacotherapy in the Elderly Judy Wong
New Zealand College of Pharmacists
Chapter 6 Drug Interactions 1.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
1 DRUG – DRUG INTERACTIONS Dr.Abdul latif Mahesar King Saud University May 2010.
Prepared By Dr Shaheen Delivered By Dr Naser
Factors Affecting Drug Activity Chapter 11 Pages
Drug metabolism Prof. M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General pharmacology.
Pharmacokinetics: Bioavailability Asmah Nasser, M.D.
Pharmacogenetics Definitions – Pharmacogenetics: single gene differences among population groups and the effects on pharmacodynamics. – Pharmacegenomics:
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
PHARMACOKINETICS.
Renal Excretion of Drugs
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Pharmacology Department
Renal Excretion of Drugs Prof. Hanan Hagar Pharmacology Department.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
1 Adverse effect of drugs Excessive Pharmacologic Effects –overdoing the therapeutic effect –Atropine –muscarinic antagonist, desired therapeutic –Effect:
PHAR 751 Pharmacogenomics
PHARMACOKINETICS Part 3.
Prof. Hanan Hagar Dr.Abdul latif Mahesar Pharmacology Department.
May 19, 2005FDA Antiviral Drugs Advisory Committee Meeting 1 Tipranavir NDA Drug Interactions Yuanchao (Derek) Zhang, Ph.D. Clinical Pharmacology.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
How drugs Act :General principles Lecture 2
Concepts of drug disposition Pharmacology Department
© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.
Challenges to drug design Did you know? Over 2 million people are hospitalized each year for adverse reactions to prescription drugs. Over 2 million.
DRUG INTERACTIONS I Lecture #36. Drug Interactions Terms Therapeutic Drug Interaction ADR Additive Synergism.
Metabolic Stability Lee, Sang-Hwi. -2- Overview Metabolism is the enzymatic modification of compounds to increase clearance. It is a determinant.
At the end of this lecture, the students will be able to: 1.Define receptors 2.Define agonists 3.List types of agonists 4. Define antagonists 5. List.
Pharmacokinetics 2 General Pharmacology M212
Foundation Knowledge and Skills
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
Basic Concepts of Pharmacology © Paradigm Publishing, Inc.
Drug efficacy is questioned.. Variation in drug responses.
Renal Excretion of Drugs Pharmacology Department
PRINCIPLES OF ANTIBIOTIC THERAPY
Basic Principles: PK By: Alaina Darby.
Pharmacogenomics: towards personalized medicine
Eucrisa™ - Crisaborole
Renal Excretion of Drugs
Pharmacogenetics and New Drug Discovery
Toxicology Drug Poisioning.
Pharmacokinetics.
Enzymes and drugs P450 enzymes breakdown/metabolize active drug
By: Dr. Roshini Murugupillai
Drug Metabolism Drugs are most often eliminated by biotransformation and/or excretion into the urine or bile. The process of metabolism transforms lipophilic.
Christine L.H. Snozek, Dennis J. O'Kane, Alicia Algeciras-Schimnich 
Drug Elimination Drug elimination consists of 2 processes
Pharmacokinetics.
Understanding the Basics of Pharmacology
Recent Advancement In Therapeutics ZURAMPIC ( LESINURAD)
FACTORS AFFECTING DRUG ACTIVITY
Toxicology Drug Poisioning.
Beatriz Pérez González 2017/18 Genomics
Pharmacokinetics Chapter 4
Pharmacologic Principles – Chapter 2
Conceptual Subdivisions of Pharmacology
Conceptual Subdivisions of Pharmacology
Clinical Pharmacokinetics
Basic Biopharmaceutics
Pharmacogenetics and Pharmacoepidemiology “PHCY 480”
Introduction to Pharmacology
Christine L.H. Snozek, Dennis J. O'Kane, Alicia Algeciras-Schimnich 
BIOAVAILABILITY.
Presentation transcript:

Pharmacology Tutoring – Factors Affecting Drug Action By Alaina Darby adarby1@uthsc.edu

Which of the following is not a drug metabolizing enzyme that can influence pharmacogenomics? CYPs UGT VKORC1 HLA-B*1502 D

Causes chelation of some drugs Causes alterations in GI transit time Which of the following is true of infection as a factor affecting absorption? Causes chelation of some drugs Causes alterations in GI transit time Causes decreased weak acid absorption Causes decreased weak base absorption D

The plasma levels of which of the following drugs is increased with OATP mutations? Fexofenadine Digoxin Simvastatin Nelfinavir C

Which of the following is not true of competition for protein binding? Consequences are dependent upon Vd Consequences are dependent upon therapeutic index There are many clinically relevant interactions Sulfonamide competes with bilirubin to cause kernicterus C

Which of the following is true of CYP induction and inhibition? Inhibition usually causes long-lasting action Induction is usually transient Alcohol inhibits enzymes Suicide inhibitors cause longer-lasting action D

Inducer increases drug concentration above therapeutic index Which of the following might cause a toxicity that can be seen in a patient? Inducer increases drug concentration above therapeutic index Inhibitor decreases drug concentration below therapeutic index Inducer decreases drug concentration below therapeutic index Inhibitor increases drug concentration above therapeutic index D

Which of the following is an organic acid that can inhibit tubular secretion? Acetylcholine Probenecid Histamine Quinine B

NaHCO3 administered to increase urine pH Which of the following would be true when trying to decrease streptomycin reabsorption? NaHCO3 administered to increase urine pH NaHCO3 administered to decrease urine pH NH4Cl administered to increase urine pH NH4Cl administered to decrease urine pH A

Atropine and tubocurarine Propranolol and morphine Which of the following would cause competition at the receptor site and antagonize the effects of the other? Atropine and tubocurarine Propranolol and morphine Atropine and acetylcholine Acetylcholine and neostigmine C

Active drug with active metabolites Reduction of enzymatic activity would most greatly decrease the efficacy of which of the following drugs? Active drug with active metabolites Active drug with inactive metabolites Inactive drug with active metabolites Inactive drug with inactive metabolites C

Which of the following is true of clinical trials? The strength of uncontrolled studies is to determine prognostic effects of genetic markers The strength of uncontrolled studies is to determine predictive effects of genetic markers The strength of controlled studies is to determine prognostic effects of genetic markers The strength of controlled studies is to determine predictive effects of genetic markers D

Recombinant drug metabolizing enzymes Primary human cell lines Which of the following can be used to closely model in-vivo systems but only has a limited number of cells? Recombinant drug metabolizing enzymes Primary human cell lines Immortalized human cell lines Induced pluripotent cells from human blood B

Which of the following is true of genome effects? Irinotecan exerts toxic effects through mutations in UGT encoded by the human genome Irinotecan exerts toxic effects through mutations in UGT encoded by the tumor genome Gefitinib exerts toxic effects through mutations in EGFR encoded by the human genome Gefitinib exerts toxic effects through mutations in EGFR encoded by the tumor genome A

Which of the following pairs of enzymes are most indicative of bleeding risk in warfarin therapy? VOKRC1 and CYP3A4 VOKRC1 and CYP2C9 CYP2C9 and CYP4F2 CYP2C9 and CYP3A4 B

N-desmethyl-tamoxifen 4-hydroxy-N-desmethyl-tamoxifen Which of the following is the most clinically relevant metabolite of tamoxifen? N-desmethyl-tamoxifen 4-hydroxy-N-desmethyl-tamoxifen 4-hydroxy-tamoxifen N-didesmethyl-tamoxifen B

Rapid CYP2D6 and rapid CYP3A4 metabolism Which of the following combinations of CYP’s can induce renal failure in codeine administration? Rapid CYP2D6 and rapid CYP3A4 metabolism Rapid CYP2D6 and inhibited CYP3A4 metabolism Inhibited CYP2D6 and rapid CYP3A4 metabolism Inhibited CYP2D6 and inhibited CYP3A4 metabolism B

Tyrosine kinase inhibition Hapten-peptie complexes T-cell receptors Which of the following is not thought to contribute to contribute to drug hypersensitivity reactions such as Stevens Johnsons Syndrome? HLA alleles Tyrosine kinase inhibition Hapten-peptie complexes T-cell receptors B